Gilead Sciences (GILD) Misses Q1 EPS by 10c
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $138.36 --0%
Financial Fact:
Cost of goods sold: 1.13B
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Cost of goods sold: 1.13B
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $3.03, $0.10 worse than the analyst estimate of $3.13. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $8.08 billion. Gilead Sciences reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- Morgan Stanley Starts Target Hospitality (TH) at Overweight
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
